A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma
A phase 3 trial testing SCTB35 in follicular lymphoma, now recruiting.
Overview
A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma is a phase 3 interventional study registered as NCT07562022, led by Sinocelltech, and recruiting when checked on 2026-09-11. Official title: A Phase 3 Randomised, Open-label, Multicenter Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide Versus Rituximab and Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma. Planned enrolment is 93 participants (estimated). The study started in 2026-06-09 and primary completion is expected in 2028-05. No results have been posted on ClinicalTrials.gov.
Similar pages
not linked directly; found by shared links- TrialA Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Shares SCTB35, Sinocelltech and the tag ctgov-ingest.
- TrialA Study to Evaluate the Safety and Tolerability of SCTB14 as First-Line Therapy in Non-Small Cell Lung Cancer
Shares Sinocelltech and the tag ctgov-ingest.
- TrialSCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer
Shares Sinocelltech and the tag ctgov-ingest.
- TrialA Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Shares Sinocelltech and the tag ctgov-ingest.
- TrialA Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Shares Follicular lymphoma and the tag ctgov-ingest.
- TreatmentSCTB14
Shares Sinocelltech and the tag ctgov-ingest.
- TreatmentSCTB41
Shares Sinocelltech and the tag ctgov-ingest.
- TreatmentSCTC21C
Shares Sinocelltech and the tag ctgov-ingest.